Curetis AG and Cempra, Inc. Collaborate on the Detection of Community-Acquired Bacterial Pneumonia
12:55 EDT 11 Aug 2012 | LaMerie
Cempra to use Curetis' Unyvero solution in its Phase III trial of its antibiotic Solithromycin (CEM-101)
Original Article: Curetis AG and Cempra, Inc. Collaborate on the Detection of Community-Acquired Bacterial Pneumonia
More From BioPortfolio on "Curetis AG and Cempra, Inc. Collaborate on the Detection of Community-Acquired Bacterial Pneumonia"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
